Haemopoietic stem-cell transplantation for systemic sclerosis

Author: K. Sullivan, F. Wigley, C. Denton, J. van Laar, D. Furst
Date Published: January-2012
Source: The Lancet

Richard Burt and colleagues (Aug 6, p 498)1 propose, on the basis of a single-centre trial of 19 patients, that autologous haemopoietic stem-cell transplantation (HSCT) might be the new standard of care for diffuse systemic sclerosis. Although the study strongly supports the use of immunosuppression in systemic sclerosis, several limitations are to be noted.


AddThis Social Bookmark Button